Next Article in Journal
Insights into the Role of Neuroinflammation in the Pathogenesis of Multiple Sclerosis
Previous Article in Journal
Effects of Pre-Workout Supplements on Power Maintenance in Lower Body and Upper Body Tasks
Previous Article in Special Issue
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy
Article Menu
Issue 1 (March) cover image

Export Article

Open AccessReview
J. Funct. Morphol. Kinesiol. 2018, 3(1), 12;

PKC Proteins and Muscular Dystrophy

Sport and Exercise Medicine Centre (SEM), Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy
Unit Biomedical, Biotechnological and Translational Sciences (SBiBiT), Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy
Anatomy and Histology Section, Department of Morphology and Experimental Medicine and Surgery, University of Ferrara, 44121 Ferrara, Italy
Author to whom correspondence should be addressed.
Received: 22 December 2017 / Revised: 30 January 2018 / Accepted: 5 February 2018 / Published: 7 February 2018
(This article belongs to the Special Issue Muscular Dystrophy)
Full-Text   |   PDF [882 KB, uploaded 7 February 2018]   |  


Protein Kinase Cs (PKCs) are a family of 10 isoenzymes with critical roles in cell physiological processes like proliferation, differentiation, apoptosis. Muscular dystrophies are a heterogenous group of genetic degenerative diseases that affect skeletal and cardiac muscles. In the development of muscular dystrophies, several transduction pathways have been studied. A possible link between muscular dystrophies and PKCs have been recently proposed. After a brief description of the possible transduction pathways that are involved in the development of these genetic diseases, we summarize recent evidence on the role of PKC proteins in muscular dystrophies, with the aim to review possible candidates in molecular therapy of these pathologies. View Full-Text
Keywords: PKCs; muscular dystrophies; cell signaling pathways PKCs; muscular dystrophies; cell signaling pathways

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Gobbi, G.; Galli, D.; Carubbi, C.; Neri, L.M.; Masselli, E.; Pozzi, G.; Vitale, M.; Mirandola, P. PKC Proteins and Muscular Dystrophy. J. Funct. Morphol. Kinesiol. 2018, 3, 12.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics



[Return to top]
J. Funct. Morphol. Kinesiol. EISSN 2411-5142 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top